Intravenous physostigmine treatment of Alzheimer’s disease evaluated by psychometric testing, regional cerebral blood flow measurement, and EEG - Gustafson,L.; Edvinsson,L.; Dahlgren,N.; Hagberg,B.; Risberg,J.; Rosén,I.; Fernö,H. (Psychopharmacology, 1987)